Journal Articles Cancers Year : 2018

Lung Cancer Screening, Towards a Multidimensional Approach: Why and How?

Abstract

Early-stage treatment improves prognosis of lung cancer and two large randomized controlled trials have shown that early detection with low-dose computed tomography (LDCT) reduces mortality. Despite this, lung cancer screening (LCS) remains challenging. In the context of a global shortage of radiologists, the high rate of false-positive LDCT results in overloading of existing lung cancer clinics and multidisciplinary teams. Thus, to provide patients with earlier access to life-saving surgical interventions, there is an urgent need to improve LDCT-based LCS and especially to reduce the false-positive rate that plagues the current detection technology. In this context, LCS can be improved in three ways: (1) by refining selection criteria (risk factor assessment), (2) by using Computer Aided Diagnosis (CAD) to make it easier to interpret chest CTs, and (3) by using biological blood signatures for early cancer detection, to both spot the optimal target population and help classify lung nodules. These three main ways of improving LCS are discussed in this review.
Fichier principal
Vignette du fichier
Benzaquen et al.pdf (973) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

hal-02045478 , version 1 (22-02-2019)

Identifiers

  • HAL Id : hal-02045478 , version 1

Cite

Jonathan Benzaquen, Jacques Boutros, Charles Marquette, Hervé Delingette, Paul Hofman. Lung Cancer Screening, Towards a Multidimensional Approach: Why and How?. Cancers, 2018, 10. ⟨hal-02045478⟩
107 View
206 Download

Share

More